Is Cytogenetic Damage a Biomarker for The Risk of Malignancy Development In Renal Transplantation Patients?

Journal Title: Hippocrates Medical Journal - Year 2022, Vol 2, Issue 1

Abstract

Abstract Introduction The micronucleus (MN) formation in the peripheral blood lymphocytes can be usable as a biomarker for the risk of cancer development. In this study, we aimed to evaluate the relationship between the MN formation in peripheral lymphocytes and the development of malignancy in renal transplant patients. Materials and Methods Ten renal transplant patients with post-transplant malignancy were included in the study. The control group with renal transplantation consisted of 15 age and sex matched renal transplant patients without post-transplant malignancy. The healthy control group consisted of 12 individuals who had similar age and sex ratios as the other two groups. The cytokinesis-block micronucleus (CBMN) assay was used for MN analysis. Results The number of MN in mononuclear cells was significantly higher in renal transplant patients with or without malignancy than in healthy controls [7.5 (2.0-11.0), 5.0 (0-12.0), and 1.0 (0-9.0), respectively, p<0.001]. Similarly, the number of MN in binuclear cells was significantly higher in renal transplant patients with or without malignancy than in healthy controls [54.0 (8.0-199.0), 32.0 (0-182.0), and 10.0 (2.00- 29.00), respectively, p<0.001]. Although the difference was not statistically significant, the number of MN both in mononuclear cells and in binuclear cells was higher in renal transplant patients with malignancy than renal transplant patients without malignancy. Conclusion Increase in the number of MN in mononuclear and binuclear cells may be a promising biomarker for malignancy development after renal transplantation

Authors and Affiliations

Emel MUTLU, Aydın ÜNAL, Aslıhan KİRAZ, Arzu TASDEMİR, Tuba Dilay ÜNAL, İsmail KOÇYİĞİT, Murat SİPAHİOĞLU, Bülent TOKGÖZ

Keywords

Related Articles

Psychosocial Factors in The Development of Postpartum Depression; A Case Control Study

Objective In this study, it was aimed to enable early detection of women at risk by investigating the factors affecting postpartum depression (PPD), which is not a health problem experienced by the mother alone, but whi...

Evaluation of Bilateral Foot Deformity in Patients with Hemiplegic Type Cerebral Palsy

Aim The aim of our study is to determine the potential degree of the deformity that may occur on the healthy foot, which is often neglected during treatment, in the case that the patient can walk independently, by evalu...

Characteristics of Trauma Patients Admitted to a Tertiary Care University Hospital Emergency Service: One year Cross-sectional Analysis

Introduction : Trauma is a important cause of mortality and morbidity in the world. Lay out and prevent the causes of trauma will significantly affect the quality of patient care and the quality of patients' lives. The p...

Clinical Approach to Obesity in Primary Care

Obesity is a multifactorial and multisystemic pathogenic condition that causes an increased risk of many diseases. As one of the major causes of preventable deaths, it also heavily features among the leading health probl...

Is Isolated Coronary Artery Bypass Grafting Sufficient to Treat Moderate Chronic Ischemic Mitral Regurgitation?

Abstract Objective Approach to ischemic mitral regurgitation is one of the most challenging areas of cardiovasculary surgery. Since it is primaryly due to left ventricular disturbances rather than mitral valve patholog...

Download PDF file
  • EP ID EP702905
  • DOI https://doi.org/10.29228/HMJ.8
  • Views 66
  • Downloads 0

How To Cite

Emel MUTLU, Aydın ÜNAL, Aslıhan KİRAZ, Arzu TASDEMİR, Tuba Dilay ÜNAL, İsmail KOÇYİĞİT, Murat SİPAHİOĞLU, Bülent TOKGÖZ (2022). Is Cytogenetic Damage a Biomarker for The Risk of Malignancy Development In Renal Transplantation Patients?. Hippocrates Medical Journal, 2(1), -. https://europub.co.uk/articles/-A-702905